Respiratory Syncytial Virus-related Death in Children With Down Syndrome The RSV GOLD Study

被引:20
|
作者
Lowensteyn, Yvette N. [1 ]
Phijffer, Emily W. E. M. [1 ]
Simons, Juliette V. L. [1 ]
Scheltema, Nienke M. [1 ]
Mazur, Natalie I. [1 ]
Nair, Harish [2 ,3 ]
Bont, Louis J. [1 ,3 ]
机构
[1] Univ Med Ctr Utrecht, Dept Pediat, Div Infect Dis, Utrecht, Netherlands
[2] Univ Edinburgh, Resp Viral Epidemiol Grp, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[3] Resp Syncytial Virus Network ReSViNET Fdn, Zeist, Netherlands
基金
比尔及梅琳达.盖茨基金会; 英国惠康基金;
关键词
Down syndrome; respiratory syncytial virus; acute respiratory tract infection; mortality; YOUNG-CHILDREN; HIGH-RISK; RECURRENT WHEEZE; HOSPITALIZATION; INFECTIONS; INFANTS; DISEASE; BURDEN; PALIVIZUMAB;
D O I
10.1097/INF.0000000000002666
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Respiratory syncytial virus (RSV) is a major cause of mortality in children younger than 5 years worldwide. Systematic reviews have shown that Down syndrome (DS) is an independent risk factor for severe RSV infection. We aimed to describe demographic and clinical characteristics of children with DS who died with RSV infection. Methods: We performed a retrospective case series in which data were shared by individual researchers, research networks and physicians worldwide as part of the RSV Global Online Database study. We included children with DS who died when younger than 5 years of age with laboratory-confirmed RSV infection. Results: We included 53 children with DS and RSV-related mortality from 20 countries in 5 continents. Five (9.4%) children were from low-income or lower-middle-income countries. Median age at time of death was 6.0 months [interquartile range (IQR): 3.00-12.0]. Thirteen (24.5%) children were born term and had no other risk factors for severe RSV disease. In total, 36 (67.9%) children had congenital heart disease, 8 (15.1%) had chronic lung disease and 1 (1.9%) had congenital immunodeficiency. Duration of hospitalization was significantly longer for children with DS compared with children without DS [median length of stay, 13 days (IQR: 6.8-21.0) vs. 8 days (IQR: 3.0-18.5),P=0.005]. Conclusions: One-fourth of children with DS and RSV-confirmed death did not have risk factors for severe RSV disease, indicating that DS is an important risk factor for RSV-related mortality. Age distribution at time of death demonstrates that maternal vaccination would not be sufficient to protect children with DS against RSV-related mortality.
引用
收藏
页码:665 / 670
页数:6
相关论文
共 50 条
  • [31] Recurrent Wheeze Following Respiratory Syncytial Virus Bronchiolitis in Children with Down Syndrome.
    Bloemers, B. L. P.
    van Furth, A. M.
    Weijerman, M. E.
    Gemke, R. J. B. J.
    Broers, C. J. M.
    Kimpen, J. L. L.
    Bont, L. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [32] Children with Down Syndrome Are High-Risk for Severe Respiratory Syncytial Virus Disease
    Stagliano, David R.
    Nylund, Cade M.
    Eide, Matilda B.
    Eberly, Matthew D.
    JOURNAL OF PEDIATRICS, 2015, 166 (03): : 703 - U1019
  • [34] RESPIRATORY SYNCYTIAL VIRUS (RSV) IN BOVINE PRACTICE
    GABATHULER, K
    SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 1983, 125 (03): : 149 - 153
  • [35] The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study
    Trautmannsberger, Ilona
    Plagg, Barbara
    Adamek, Ina
    Mader, Silke
    de Luca, Daniele
    Esposito, Susanna
    Silfverdal, Sven Arne
    Zimmermann, Luc J. I.
    Tischer, Christina
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (07) : 1531 - 1573
  • [36] MODES OF SPREAD OF RESPIRATORY SYNCYTIAL VIRUS (RSV)
    HALL, CB
    DOUGLAS, RG
    PEDIATRIC RESEARCH, 1980, 14 (04) : 558 - 558
  • [37] Clinical characteristics and prognosis of paediatric respiratory syncytial virus-related encephalopathy
    He, Yushan
    Liu, Gang
    Zhuo, Xiuwei
    Tian, Xiaojuan
    Liu, Jun
    Xu, Xiaomeng
    Qian, Suyun
    ITALIAN JOURNAL OF PEDIATRICS, 2024, 50 (01)
  • [38] Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease
    Tartof, Sara Y.
    Aliabadi, Negar
    Goodwin, Gabriella
    Slezak, Jeff
    Hong, Vennis
    Ackerson, Bradley
    Liu, Qing
    Shaw, Sally
    Welsh, Sabrina
    Stern, Julie A.
    Kapadia, Banshri
    Spence, Brigitte C.
    Lewnard, Joseph A.
    Davis, Gregg S.
    Aragones, Michael
    Dutro, Michael
    Chilson, Erica
    Gonzalez, Elisa
    Hubler, Robin
    Chia, Brandon
    Jodar, Luis
    Gessner, Bradford D.
    Begier, Elizabeth
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [39] Incidence of respiratory syncytial virus-related hospitalizations in high-risk children:: Follow-up of a national cohort of infants treated with palivizumab as RSV prophylaxis
    Lacaze-Masmonteil, T
    Rozé, JC
    Fauroux, B
    PEDIATRIC PULMONOLOGY, 2002, 34 (03) : 181 - 188
  • [40] Can Respiratory Syncytial Virus (RSV) Infection in Children Be Eliminated Through Immunization?
    Glasper, Edward Alan
    COMPREHENSIVE CHILD AND ADOLESCENT NURSING-BUILDING EVIDENCE FOR PRACTICE, 2023, 46 (01): : 5 - 7